Navigation Links
Evidence-Based Heart Attack Care Reduces Deaths: Study
Date:4/27/2011

By Jenifer Goodwin
HealthDay Reporter

TUESDAY, April 26 (HealthDay News) -- The increased use of evidence-based treatments for heart attacks, such as clot-busting drugs and rapid angioplasty, has led to a decrease in deaths, a new study finds.

Researchers used data from a Swedish coronary care registry on more than 61,000 patients who had had a particular type of deadly heart attack known as STEMI between 1996 and 2007.

During those 12 years, the use of evidence-based treatments -- that is, treatments that were shown in large-scale, randomized medical studies to work -- became more widespread, according to the study.

That corresponded with a drop in deaths from that type of heart attack, the investigators found.

From 1996 to 2007, in-hospital deaths in Sweden fell from 12.5 percent to 7.2 percent. Deaths within a month of the heart attack fell from 15 percent to 8.6 percent, and deaths within a year of the heart attack dropped from 21 percent to 13.3 percent, according to the report.

The percentage of patients who had a second heart attack while in the hospital also fell from 4 percent at the start of the study period to 1 percent by the study's end.

Though this research was conducted in Sweden, experts said they'd expect to see a similar trend in the United States, where evidence-based treatments are also increasingly taking hold at the nation's hospitals.

"The combined use of simple therapies such as aspirin and cholesterol-lowering medications and balloon stents were associated with a significant reduction in mortality," said Dr. Debabrata Mukherjee, chief of cardiology at Texas Tech University Health Sciences Center. "We would expect to have similar findings in the United States."

Mukherjee wrote an editorial accompanying the study in the April 27 issue of the Journal of the American Medical Association.

Numerous therapies became more commonplace between 1996 and 2
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Evidence-based care and outcomes improve at Get With The Guidelines-Stroke hospitals
2. Pew Applauds Federal Grant Program Supporting State Expansion of Evidence-Based Home Visitation
3. Elseviers Journal of Evidence-Based Dental Practice celebrates 10th year with special issue
4. Evidence-based medicine theory can be applied to frequent flying says US professor
5. Space Coast Cancer Center Selects Via Oncology™ Pathways to Advance Evidence-Based Cancer Care
6. Real-time, evidence-based information at clinicians fingertips to streamline mental health care
7. Clinical practitioners not adhering to evidence-based guidelines for osteoarthritis
8. ICU Patients at Risk for Rare Heart Rhythm Problem
9. Cook With Love This Valentines Day With Heart-Smart Recipes
10. Study finds racial gaps continue in heart disease awareness
11. Highmark Foundation Awards $120,000 to the American Heart Association
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Evidence-Based Heart Attack Care Reduces Deaths: Study 
(Date:8/27/2014)... (PRWEB) August 27, 2014 ... governance, and compliance software solutions for next-generation social ... Inc. magazine’s Inc. 500|5000, an exclusive ranking of ... consecutive year. AvePoint joins brands such as Alex ... 2014 edition. , This underscores continued growth ...
(Date:8/27/2014)... BambooIndustry.com is one of the most loved online bamboo product ... sale now. Recently, it has announced its new selection of ... BambooIndustry.com strives to offer one-stop shopping solutions for people who ... Now, it is providing big discounts for all the brand ... enjoy a discounted price (up to 30% off) before the ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 AttorneyOne.com, a ... all the latest information from the FDA on ... on August 1, that Organic Raw Carob Powder sold ... recalled due to possible contamination with Salmonella. ... with weakened immune systems. In healthy people it can ...
(Date:8/27/2014)... Crossing, PA (PRWEB) August 27, 2014 Time ... successfully launched its first-ever golf event! , With 80-degree ... for the Time To Play Golf (TTPGolf) Inaugural Outing. Around ... August 4th event, staged at the beautiful Heron Glen Golf ... with a bang and everyone seemed to be having a ...
(Date:8/27/2014)... OR (PRWEB) August 27, 2014 The ... improve quality of life and may eliminate the need ... controversy. During a recent AllMed webinar, Dr. Zanhua Yi, ... issues related to determining medical necessity of erythropoiesis-stimulating agents ... disease (CKD). , The U.S. Food and Drug Administration ...
Breaking Medicine News(10 mins):Health News:Inc. Magazine Names AvePoint to the Inc. 500|5000 List of Fastest Growing American Companies for the Fifth Consecutive Year 2Health News:Inc. Magazine Names AvePoint to the Inc. 500|5000 List of Fastest Growing American Companies for the Fifth Consecutive Year 3Health News:Brand New Bamboo Plywoods Now Offered At BambooIndustry.com 2Health News:Organic Raw Carob Powder by Sunburst SuperFoods Recalled: AttorneyOne Monitors and Keeps Consumers Informed 2Health News:Recap: Time To Play Golf Inaugural Golf Outing 2Health News:AllMed Webinar Helps Health Plans Determine Medical Necessity Of ESAs In The Treatment Of Chronic Kidney Disease 2Health News:AllMed Webinar Helps Health Plans Determine Medical Necessity Of ESAs In The Treatment Of Chronic Kidney Disease 3
... The Songs of Love ... uplifting, personalized songs for children and teens struggling with a life-threatening ... professionally produced with lyrics containing the child,s name and references to ... Songs are written and performed in the musical style that the ...
... improved hearing and alleviated other symptoms in patients with ... appear in the July 23 New England Journal ... researchers from Massachusetts General Hospital (MGH) report that bevacizumab ... of NF2 patients, the first reported successful NF2 treatment ...
... The world-wide explosion of overweight people has been called ... recognized. Could it really be an epidemic involving an ... increasing prevalence of overweight conditions in our society, investigators ... as a potential direct contributor to obesity. ...
... WASHINGTON, July 8 The results of a study published ... Journal (BMJ) support the findings of a white paper released ... (SCHS) regarding the potentially lifesaving qualities of cholesterol lowering drugs ... "In patients without established cardiovascular disease but with cardiovascular risk ...
... , TROIS-RIVIERES, Quebec, July 8 The Narconon drug rehab ... involved with drug related charges due to their addiction. ... a drug addiction, and just one day gets caught by ... a representative of Narconon Trois-Rivieres. "This is an all ...
... July 8 On the heels of a new campaign launched ... to unsightly "canckles," Dr. Marc Mittleman, founder and director of ... clubs and their members to focus on a real health issue ... in warm, moist environments like locker rooms, communal showers, pool and ...
Cached Medicine News:Health News:Donate Your Car to the Songs of Love Car Donation Program 2Health News:Anti-angiogenesis treatment improves hearing in some NF2 patients 2Health News:Anti-angiogenesis treatment improves hearing in some NF2 patients 3Health News:British Medical Journal Report Supports SCHS White Paper on Statins 2Health News:Drug Crimes in Canada Cause Continuing Problems for Small Communities 2Health News:While Health Clubs Say No to 'Canckles,' Leading Podiatrists Say No to Toenail Fungus 2Health News:While Health Clubs Say No to 'Canckles,' Leading Podiatrists Say No to Toenail Fungus 3
(Date:8/26/2014)... -- Based on its recent analysis of the breast imaging solutions ... North American Frost & Sullivan Award for Technology Innovation Leadership. ... solutions for the early detection of breast cancer. Over the ... solutions and has expanded its global reach to cover ... , Asia and Australia ...
(Date:8/26/2014)... 26, 2014 Novira Therapeutics, Inc., a privately ... of chronic hepatitis B virus (HBV) infection, today announced ... appointed the Chair of its Scientific Advisory Board (SAB). ... Senior Advisor to the Company.  "We ... Chair," said Christian Schade , Chief Executive Officer ...
(Date:8/26/2014)... 2014  Zimmer Holdings, Inc. (NYSE and SIX: ZMH), a ... of Directors has approved the payment of a quarterly cash ... The cash dividend of $0.22 per share will ... of record as of the close of business on September ... of the Board of Directors and may be adjusted as ...
Breaking Medicine Technology:Frost & Sullivan Applauds Volpara Solutions' Clear Vision in Identifying the Importance of Dose Tracking and Quantitative Analytics in the Early Detection of Breast Cancer 2Frost & Sullivan Applauds Volpara Solutions' Clear Vision in Identifying the Importance of Dose Tracking and Quantitative Analytics in the Early Detection of Breast Cancer 3Frost & Sullivan Applauds Volpara Solutions' Clear Vision in Identifying the Importance of Dose Tracking and Quantitative Analytics in the Early Detection of Breast Cancer 4Frost & Sullivan Applauds Volpara Solutions' Clear Vision in Identifying the Importance of Dose Tracking and Quantitative Analytics in the Early Detection of Breast Cancer 5Novira Therapeutics Announces Appointment of Roger J. Pomerantz, M.D., F.A.C.P., as Chair of Scientific Advisory Board 2Novira Therapeutics Announces Appointment of Roger J. Pomerantz, M.D., F.A.C.P., as Chair of Scientific Advisory Board 3Novira Therapeutics Announces Appointment of Roger J. Pomerantz, M.D., F.A.C.P., as Chair of Scientific Advisory Board 4
... Calif., Dec. 6 DURECT Corporation,(Nasdaq: ... Phase III trial for Remoxy,had successfully met ... by the U.S. Food and Drug Administration ... an investigational drug based on,DURECT,s patented ORADUR(TM) ...
... Colo., Dec. 5 Replidyne, Inc.,(Nasdaq: RDYN ) ... Collins will participate on the New and Powerful Anti-infectives,panel ... panel,discussion will take place at 11:00 am ET on ... New York City., A live audio webcast of ...
Cached Medicine Technology:Primary Endpoint of Pivotal Phase III Clinical Trial Achieved for Remoxy(TM) 2Primary Endpoint of Pivotal Phase III Clinical Trial Achieved for Remoxy(TM) 3Primary Endpoint of Pivotal Phase III Clinical Trial Achieved for Remoxy(TM) 4
30 cm - 11 3/4, packages 5 pcs....
Galt Skull Trephine with adjustable centering point and detachable cross-bar handle, 19.0 mm....
23 cm - 9, adult size, for skull thickness up to 12 mm....
Width 3 (76 mm), length 6 3/4 (171 mm). Pattie Tray attaches to long or short arm....
Medicine Products: